Ghost Tree Capital, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Ghost Tree Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.07 - $16.04 $774,501 - $1.12 Million	69,964 Added 53.8%	200,000 $2.37 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $227,672 - $367,941	30,036 Added 30.04%	130,036 $1.59 Million
Q3 2023 Nov 14, 2023	BUY	$8.95 - $11.35 $894,999 - $1.14 Million	100,000 New	100,000 $963,000
Q1 2021 May 14, 2021	SELL	$14.69 - $42.57 $2.94 Million - $8.51 Million	-200,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.88 - $19.47 $1.93 Million - $2.92 Million	-150,000 Reduced 42.86%	200,000 $3.8 Million
Q1 2020 May 15, 2020	SELL	$5.8 - $18.56 $377,000 - $1.21 Million	-65,000 Reduced 15.66%	350,000 $2.68 Million
Q4 2019 Feb 14, 2020	BUY	$10.31 - $17.81 $1.03 Million - $1.78 Million	100,000 Added 31.75%	415,000 $7.39 Million
Q3 2019 Nov 14, 2019	BUY	$11.6 - $21.67 $174,000 - $325,050	15,000 Added 5.0%	315,000 $3.65 Million
Q2 2019 Aug 14, 2019	SELL	$18.44 - $30.89 $1.84 Million - $3.09 Million	-100,000 Reduced 25.0%	300,000 $6.65 Million
Q1 2019 May 15, 2019	SELL	$16.51 - $31.1 $412,750 - $777,500	-25,000 Reduced 5.88%	400,000 $11.4 Million
Q4 2018 Feb 14, 2019	BUY	$16.21 - $24.06 $3.24 Million - $4.81 Million	200,000 Added 88.89%	425,000 $8.39 Million
Q3 2018 Nov 14, 2018	BUY	$8.0 - $22.11 $1.8 Million - $4.97 Million	225,000 New	225,000 $4.98 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.